CEPI funds next phase of nanoparticle vaccine platform to support rapid outbreak response
On Jun. 2, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced New funding will support the continued…
On Jun. 2, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced New funding will support the continued…
On May 31, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) announced it will urgently accelerate development of…
On May 18, 2026, The Coalition for Epidemic Preparedness Innovations (CEPI) welcomed landmark financial commitments from two of…
On Jan. 29, 2026, a team led by researchers at Chalmers University of Technology and Oslo University Hospital,…
On Jan. 12, 2026, With support from the epidemic preparedness organisation Coalition for Epidemic Preparedness Innovations (CEPI), Serum…
On Dec. 17, 2025, A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show…
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
On Mar. 11, 2021, Johnson & Johnson announced that the European Commission (EC) had granted a Conditional Marketing…
In 1873, Gerhard-Henrik Armauer Hansen published his report that claimed leprosy to be an infectious disease with a…